BI
FBRX icon

BVF Inc’s Forte Biosciences FBRX Stock Holding History

BVF Inc’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65,350
Closed -$980K – 45
2025
Q3 		$980K Sell
65,350
-522,994
-89% -$6.02M 0.04% 44
2025
Q2 		$7.61M Sell
588,344
-5,938
-1% -$51.1K 0.27% 33
2025
Q1 		$4.61M Hold
594,282
– – 0.19% 41
2024
Q4 		$13.5M Buy
594,282
+475,000
+398% +$5.65M 0.46% 36
2024
Q3 		$668K Sell
119,282
-2
-0% -$21 0.02% 55
2024
Q2 		$1.6M Hold
119,284
– – 0.04% 54
2024
Q1 		$2.09M Hold
119,284
– – 0.06% 56
2023
Q4 		$2.45M Hold
119,284
– – 0.06% 61
2023
Q3 		$1.97M Buy
+119,284
New +$2.64M 0.05% 63
2021
Q3 		– Sell
-23,672
Closed -$19.9M – 77
2021
Q2 		$19.9M Sell
23,672
-5,080
-18% -$4.58M 0.75% 37
2021
Q1 		$24.6M Hold
28,752
– – 0.92% 31
2020
Q4 		$26.2M Sell
28,752
-2,350
-8% -$2.21M 1.03% 27
2020
Q3 		$37.7M Sell
31,102
-8,052
-21% -$5.34M 2.05% 20
2020
Q2 		$14.3M Buy
+39,154
New +$17.5M 0.88% 33
2018
Q3 		– Sell
-1,256
Closed -$4.4M – 58
2018
Q2 		$4.4M Sell
1,256
-89
-7% -$326K 0.43% 44
2018
Q1 		$5.98M Sell
1,345
-139
-9% -$644K 0.61% 32
2017
Q4 		$5.71M Sell
1,484
-1,351
-48% -$5.39M 0.69% 33
2017
Q3 		$13.2M Sell
2,835
-576
-17% -$2.57M 1.68% 20
2017
Q2 		$15.4M Buy
+3,411
New +$19.2M 2.39% 14

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BVF Inc's FBRX Position: Q4 2025 in Review

BVF Inc sold out of Forte Biosciences (FBRX) in Q4 2025, closing a stake of 65,350 shares — an estimated $980K sold.

BVF Inc first reported a position in FBRX in Q2 2017 and held it in 19 quarters. The position peaked at $37.7M in Q3 2020. 59 funds tracked by Wall St. Rank hold FBRX as of Q4 2025.

  • BVF Inc reported no remaining Forte Biosciences position as of Q4 2025 after selling out during the quarter.
  • BVF Inc sold 65,350 Forte Biosciences shares in Q4 2025, an estimated $980K.
  • BVF Inc first reported a position in Forte Biosciences in Q2 2017 and held it in 19 quarters.
  • BVF Inc's Forte Biosciences position peaked at $37.7M in Q3 2020.
  • 59 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2025.

Based on BVF Inc's 13F filing for Q4 2025, filed 17 Feb 2026.